Correlation Between Sumitomo Chemical and SCANDMEDICAL SOLDK-040

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sumitomo Chemical and SCANDMEDICAL SOLDK-040 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sumitomo Chemical and SCANDMEDICAL SOLDK-040 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sumitomo Chemical and SCANDMEDICAL SOLDK 040, you can compare the effects of market volatilities on Sumitomo Chemical and SCANDMEDICAL SOLDK-040 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sumitomo Chemical with a short position of SCANDMEDICAL SOLDK-040. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sumitomo Chemical and SCANDMEDICAL SOLDK-040.

Diversification Opportunities for Sumitomo Chemical and SCANDMEDICAL SOLDK-040

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Sumitomo and SCANDMEDICAL is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Sumitomo Chemical and SCANDMEDICAL SOLDK 040 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCANDMEDICAL SOLDK 040 and Sumitomo Chemical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sumitomo Chemical are associated (or correlated) with SCANDMEDICAL SOLDK-040. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCANDMEDICAL SOLDK 040 has no effect on the direction of Sumitomo Chemical i.e., Sumitomo Chemical and SCANDMEDICAL SOLDK-040 go up and down completely randomly.

Pair Corralation between Sumitomo Chemical and SCANDMEDICAL SOLDK-040

Assuming the 90 days horizon Sumitomo Chemical is expected to under-perform the SCANDMEDICAL SOLDK-040. But the stock apears to be less risky and, when comparing its historical volatility, Sumitomo Chemical is 3.14 times less risky than SCANDMEDICAL SOLDK-040. The stock trades about -0.24 of its potential returns per unit of risk. The SCANDMEDICAL SOLDK 040 is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  76.00  in SCANDMEDICAL SOLDK 040 on August 31, 2024 and sell it today you would earn a total of  5.00  from holding SCANDMEDICAL SOLDK 040 or generate 6.58% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sumitomo Chemical  vs.  SCANDMEDICAL SOLDK 040

 Performance 
       Timeline  
Sumitomo Chemical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sumitomo Chemical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
SCANDMEDICAL SOLDK 040 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, SCANDMEDICAL SOLDK-040 is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Sumitomo Chemical and SCANDMEDICAL SOLDK-040 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sumitomo Chemical and SCANDMEDICAL SOLDK-040

The main advantage of trading using opposite Sumitomo Chemical and SCANDMEDICAL SOLDK-040 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sumitomo Chemical position performs unexpectedly, SCANDMEDICAL SOLDK-040 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCANDMEDICAL SOLDK-040 will offset losses from the drop in SCANDMEDICAL SOLDK-040's long position.
The idea behind Sumitomo Chemical and SCANDMEDICAL SOLDK 040 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals